Why does the price of Chinese patent medicine become a "rhinoceros"?

[market analysis of chinapharma.com] recently, Jilin Aodong issued a notice that the retail price of its blockbuster product Anshen Bunao liquid will be adjusted to 32 yuan / box from September 15, 2018 It is understood that its current retail price is about 25 yuan, up nearly 30% In fact, recently, many people in my circle of friends have reported that many Chinese patent medicines have increased their prices For example, the original 20 yuan Sanju yinqiao powder now needs nearly 40 yuan, Tianma Qufeng patch from 14 yuan to 28 yuan, Qingfei Huatan pill from 7.2 yuan to 24.5 yuan So, what are the reasons behind the price rise of these Chinese patent medicines? The price of raw materials is rising For the price of Chinese patent medicine, most people's reaction is that the price of Chinese herbal medicine is rising In fact, in recent years, the price of Chinese herbal medicine has also attracted great attention of the society According to the data, by the end of 2017, the price of some varieties of traditional Chinese medicine had doubled several times For example, the price of corn whisker in September is 4.5 yuan / kg, which has risen to 28 yuan in December, with an increase of more than 500%; the price of dogwood has risen to 50 yuan from 27 yuan / kg in February; the price of 270 yuan / kg at the beginning of the cicada slough year has risen to 420 yuan in August Behind the soaring price of these traditional Chinese medicine, people are worried Will it be affordable in the future? Can traditional Chinese medicine enterprises, which use traditional Chinese medicine as raw materials, survive? The increase of labor cost and packaging cost has the industry response, "the price increase of Liuwei Dihuang pill is mainly due to the increase of labor cost, which has a greater impact All rely on low value-added medicinal materials The raw materials are mainly affected by labor cost " At the same time, he said, compared with the price in 2016, the price of cartons has increased by 55%, and the price of cartons has also increased by 20% The increase of labor cost and packaging material cost will undoubtedly promote the price of Chinese patent medicine products Therefore, how to reduce the labor cost and realize the optimization benefit is a big problem for Chinese patent medicine manufacturers In recent years, the national supervision is more and more strict, which also forces the relevant production enterprises to improve and upgrade the production mode in order to meet the regulatory requirements To a certain extent, it also brings pressure to the investment of enterprises For example, in order to ensure the quality of raw materials, CIIC pharmaceutical and Lizhu group also set up their own gap production base When the market is in short supply, or there is monopoly or relative monopoly, the price of products will inevitably rise For example, products such as vitamin C Yinqiao Tablets, Banlangen Granules, Niuhuang Jiedu Tablets, etc are in great demand in the market, and sometimes they will be out of stock, and their costs rise to a certain extent in line with the market law However, there are also reactions, among which there is a surge in APIs, or some enterprises use monopoly status and artificial speculation factors In response to this situation, the industry believes that the blow will be hit, and the heavy punishment will be heavy punishment In addition, traditional Chinese medicine is a special commodity In response to the sudden rise of some medicinal materials, the industry suggests that pharmaceutical enterprises should establish an information monitoring and early warning system for key varieties, grasp the price changes of raw materials and medicines, and collect and store them in advance, so as to reduce the production cost pressure after the price rise There are always two sides to the development of things According to the "medicine market cycle theory" of "five years a small rise, ten years a big rise", this year should be a new round of rising prices of Chinese herbal medicines If 2018 is really the year when the price of traditional Chinese medicine is soaring, then traditional Chinese medicine will really become a noble medicine!